🇺🇸 FDA
Pipeline program

SPN-812 (600mg, QD)

812P418

Approved small_molecule completed

Quick answer

SPN-812 (600mg, QD) for Healthy Lactating Women is a Approved program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SUPERNUS PHARMACEUTICALS, INC.
Indication
Healthy Lactating Women
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials